Everspin Technologies Inc (MRAM)

Everspin Technologies (MRAM) Income Statement


Everspin Technologies Income Statement

Last quarter (Q4 2023), Everspin Technologies's total revenue was $16.71M, an increase of Infinity% from the same quarter last year. In Q4, Everspin Technologies's net income was $1.97M. See Everspin Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 63.77M$ 63.77M$ 59.98M$ 55.15M$ 42.03M$ 37.50M
Cost of Revenue
$ 26.52M$ 26.52M$ 26.04M$ -22.07M$ 23.94M$ 19.17M
Gross Profit
$ 37.24M$ 37.24M$ 33.95M$ 33.07M$ 18.09M$ 18.33M
Operating Expense
$ 31.36M$ 31.36M$ 27.72M$ -28.04M$ 25.65M$ 31.96M
Operating Income
$ 5.88M$ 5.88M$ 6.23M$ 5.04M$ -7.56M$ -13.63M
Net Non Operating Interest Income Expense
$ -63.00K$ -63.00K$ -274.00K$ -547.00K$ -665.00K$ -747.00K
Other Income Expense
$ -3.21M$ -3.21M$ -190.00K$ 141.00K$ -24.00K$ -292.00K
Pretax Income
$ 9.04M$ 9.04M$ 6.14M$ 4.35M$ -8.25M$ -14.67M
Tax Provision
$ -16.00K$ -16.00K$ 14.00K$ 4.00K$ 260.00K$ 0.00
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 9.05M$ 9.05M$ 6.13M$ 4.34M$ -8.51M$ -14.67M
Basic EPS
$ 0.44$ 0.44$ 0.30$ 0.22$ -0.45$ -0.85
Diluted EPS
$ 0.42$ 0.42$ 0.29$ 0.22$ -0.45$ -0.85
Basic Average Shares
$ 82.99M$ 20.75M$ 20.13M$ 19.40M$ 18.78M$ 17.32M
Diluted Average Shares
$ 85.47M$ 21.37M$ 20.78M$ 19.97M$ 18.78M$ 17.32M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 57.88M$ 57.88M$ 53.76M$ 50.11M$ 49.59M$ 51.13M
Net Income From Continuing And Discontinued Operation
$ 9.05M$ 9.05M$ 6.13M$ 4.34M$ -8.51M$ -14.67M
Normalized Income
$ 6.93M$ 9.02M$ 4.85M-$ -8.51M$ -13.89M
Interest Expense
----$ 665.00K$ 747.00K
$ 9.10M$ 9.10M$ 6.42M$ 4.89M$ -7.59M$ -13.92M
$ 10.33M$ 10.33M$ 7.50M$ 6.67M$ -5.61M$ -12.23M
Currency in USD

Everspin Technologies Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis